Dr John Thymis (Attikon University Hospital, Athens, GR) presents the results of his trial that investigated the effects of GLP1 receptor agonists and SGLT2 inhibitors and their combination on vascular function and MWI in patients with type 2 diabetes. 

Recorded remotely from Athens, 2020. 

This presentation was supported by an unrestricted educational grant from Novo Nordisk.